The company claims that its R&D has developed an innovative blend of specific clinically evaluated probiotic strains that together could suppress nasal allergies and be useful in managing conditions ...
Drug regulator suspends manufacturing and selling of Entod pharma's eye drops over unapproved claims
The DCGI has halted the authorization given to Mumbai-based Entod Pharmaceuticals to produce and market its novel eye drops, citing the company's assertions that it can assist individuals with ...
Due to safety concerns and unauthorised claims, the Central Drugs Standard Control Organisation (CDSCO) of India has suspended the manufacturing and marketing license of Entod Pharmaceuticals’ PresVu ...
Established in 1977 by the late GV Masurkar, Entod Pharmaceuticals will be celebrating its foundation day on July 11 on the occasion of the 100th birth anniversary of its founder. A visionary leader ...
PresVu is the result of years of dedicated research and development, the company claims. (Image Credits: Pixabay) Days, after ENTOD Pharmaceuticals announced that it has received final approval from ...
Entod Pharmaceuticals, one of India’s leading and fastest growing ophthalmic specialty pharmaceutical companies, has announced a significant global milestone in eye care therapeutics with the ...
New Delhi: ENTOD Pharmaceuticals unveiled its latest initiative, "FUR by ENTOD (Veterinary)," a specialised division devoted to providing innovative Eye and Ear Care medicines for pets. The diverse ...
This gel serum is soothing, cooling, non-sticky and non-irritant on the skin around the eyes. ENTOD Pharmaceuticals in collaboration with the UK based cosmetic research laboratory NuSkin London has ...
In a move to expand its business, Entod Pharmaceuticals on Monday announced launch of GLO division, an ophthalmic subspeciality division focused on the treatment of glaucoma, a leading cause of ...
ENTOD Pharmaceuticals on Tuesday announced that it has received approval from Drug Controller General of India (DCGI) to carry out phase 3 trials across the country for their 0.05 per cent atropine ...
Entod Pharmaceuticals expects to roll out an eye drop developed to slow the progression of myopia in children aged 6 to 12 years, by early June. The company received the Central Drugs Standard Control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results